Cadrenal Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CVKD and other ETFs, options, and stocks.About CVKD
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.
CVKD Key Statistics
Stock Snapshot
The current Cadrenal Therapeutics(CVKD) stock price is $3.63, with a market capitalization of 10.34M. The stock trades at a price-to-earnings (P/E) ratio of -0.64.
On 2026-07-05, Cadrenal Therapeutics(CVKD) stock moved within a range of $2.90 to $3.89. With shares now at $3.63, the stock is trading +25.2% above its intraday low and -6.7% below the session's peak.
Trading activity shows a volume of 107.09K, compared to an average daily volume of 110.33K.
The stock's 52-week range extends from a low of $2.55 to a high of $14.64.
The stock's 52-week range extends from a low of $2.55 to a high of $14.64.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.